Severe Demyelinating Neuropathy in an Advanced Melanoma Patient Treated with Nivolumab plus Ipilimumab Combined Therapy

Immune checkpoint inhibitors (ICIs) significantly prolong survival in patients with metastatic melanoma but can lead to serious immune-related adverse events. In this report, we described a case of atypical neuropathy caused by nivolumab plus ipilimumab combination therapy before primary tumor resec...

Descripción completa

Detalles Bibliográficos
Autores principales: Kambayashi, Yumi, Fujimura, Taku, Kuroda, Hiroshi, Otsuka, Atsushi, Irie, Hiroyuki, Aiba, Setsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250384/
https://www.ncbi.nlm.nih.gov/pubmed/32508619
http://dx.doi.org/10.1159/000506976

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7250384/
https://www.ncbi.nlm.nih.gov/pubmed/32508619
http://dx.doi.org/10.1159/000506976

Ejemplares similares